News Daily News DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain Michael O'Riordan March 04, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis Yael L. Maxwell December 24, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions L.A. McKeown December 17, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
News Daily News CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes L.A. McKeown November 01, 2021
News Daily News Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis Caitlin E. Cox October 27, 2021
News Conference News TCT 2021 De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS Yael L. Maxwell October 22, 2021
News Conference News EACTS 2021 Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First Michael O'Riordan October 19, 2021
News Conference News TCT 2021 EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI Michael O'Riordan October 15, 2021